- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Services & Solutions
Information Downloads
WuXi XDC: The Bioconjugation Leader
From Target to Market - Comprehensive Services for ADCs/Bioconjugates
|
WuXi XDC is a dedicated CRDMO providing end-to-end discovery, development, and manufacturing services for bioconjugates and antibody drug conjugates (ADCs). Our one-stop comprehensive technology platform greatly simplifies Antibody Drug Conjugate (ADC) and other bioconjugate drug development by providing lead screening and selection, preclinical activities, holistic and integrated CMC development, and the entire production supply chain, with one company and in one centralized region. |
Discuss This Service Overview
To discuss the information in this service overview, please complete the form on the following page to connect with our experts.